Evidence map›Paper›PMID 35126120›Full record

ReviewFrontiers in pharmacology2021

Platelet Mechanobiology Inspired Microdevices: From Hematological Function Tests to Disease and Drug Screening.

Yingqi Zhang, Fengtao Jiang, Yunfeng Chen, Lining Arnold Ju

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Yingqi ZhangSchool of Biomedical Engineering, Faculty of Engineering, The University of Sydney, Sydney, NSW, Australia.
Fengtao JiangSchool of Biomedical Engineering, Faculty of Engineering, The University of Sydney, Sydney, NSW, Australia.
Yunfeng ChenThe Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX, United States.
Lining Arnold JuSchool of Biomedical Engineering, Faculty of Engineering, The University of Sydney, Sydney, NSW, Australia.
University of Sydney · AUThe Heart Research Institute · AUThe University of Texas Medical Branch at Galveston · US

Funding

Inhibiting biomechanical platelet aggregation to prevent arterial thrombosis without compromising hemostasisR00HL153678 · NHLBI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI CHEN, YUNFENG · 2022 to 2024
$746k
NHLBI NIH HHS R00 HL153678
6 · The paper itself

Abstract

Platelet function tests are essential to profile platelet dysfunction and dysregulation in hemostasis and thrombosis. Clinically they provide critical guidance to the patient management and therapeutic evaluation. Recently, the biomechanical effects induced by hemodynamic and contractile forces on platelet functions attracted increasing attention. Unfortunately, the existing platelet function tests on the market do not sufficiently incorporate the topical platelet mechanobiology at play. Besides, they are often expensive and bulky systems that require large sample volumes and long processing time. To this end, numerous novel microfluidic technologies emerge to mimic vascular anatomies, incorporate hemodynamic parameters and recapitulate platelet mechanobiology. These miniaturized and cost-efficient microfluidic devices shed light on high-throughput, rapid and scalable platelet function testing, hematological disorder profiling and antiplatelet drug screening. Moreover, the existing antiplatelet drugs often have suboptimal efficacy while incurring several adverse bleeding side effects on certain individuals. Encouraged by a few microfluidic systems that are successfully commercialized and applied to clinical practices, the microfluidics that incorporate platelet mechanobiology hold great potential as handy, efficient, and inexpensive point-of-care tools for patient monitoring and therapeutic evaluation. Hereby, we first summarize the conventional and commercially available platelet function tests. Then we highlight the recent advances of platelet mechanobiology inspired microfluidic technologies. Last but not least, we discuss their future potential of microfluidics as point-of-care tools for platelet function test and antiplatelet drug screening.

Indexed as

aspirinclopidogrelCOVID-19mechanobiologymicrofluidicsplateletthrombosisvon Willebrand disease

Identifiers

PMID35126120
PMCPMC8811026
OpenAlexW4206674219

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.